Spectrum of movement disorders in paediatric anti NMDAR encephalitis
Objective: The spectrum of movement disorders (MDs) associated with anti N-methyl-D-aspartate (NMDAR) receptor encephalitis is vast and heterogenous, particularly in children, possibilities of which were…Acute Hyperglycemia Without Ketosis Related Movement Disorders: A Case Series
Objective: report 2 patients with different types of movement disorders (MD) revealing an Acute hyperglycemia without ketosis (AHWK). Background: neurological complications of diabetes are multiple,…Lingual dystonia etiology spectrum in a tertiary center
Objective: To describe a group of patients with LP regarding clinical presentation, etiology, and treatment. Background: Lingual dystonia (LD) is a rare, disabling and difficult…Movement disorders in pediatric anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis
Objective: Our aim was to investigate clinical characteristics and evolution of movement disorders (MD) in pediatric anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis. Background: Movement disorders account for…Combined anti N-Methyl-D- Aspartate receptor (NMDAR) encephalitis with autoimmune thyroiditis (AT), with good clinical recovery.
Objective: To report anti NMDAR encephalitis patient, with evidence of AT, and to explain her clinical presentation, management and outcome. Background: Autoimmune encephalitis(AE) is nowadays…Task Specific Oromandibular dystonia due to Shisha (Hookah) Smoking- “Shisha Dystonia”
Objective: To report an unusual case of oromandibular dystonia due to repeated task of smoking shisha/hookah. Background: Focal task-specific dystonia is common in men, aged…A Case of Disabling Orofacial Dyskinesias Caused by Lupus Anticoagulant
Objective: We describe a 93-year-old man with subacute, progressive onset of disabling orofacial dyskinesias (OD), found to have positive lupus anticoagulant (LA) and anti-beta2-glycoprotein IgA…The clinical spectrum of movement disorders associated with neuronal antibodies
Objective: To describe the clinical and treatment characteristics of movement disorders associated with antibodies (Abs) against neuronal synaptic extracellular (NMDAR, LGI1, CASPR2, IgLON5, Glycine receptors…SLC20A2 mutation manifesting as very-late onset orofacial dyskinesia
Objective: We report two cases of genetically confirmed PFBC with a SLC20A2 mutation that presented with very-late onset orofacial dyskinesia. Background: Primary familial brain calcification…Acquired hepatocerebral degeneration treated with calcium disodium edetate chelation
Objective: To evaluate the efficacy of calcium disodium edetate (CaNa2EDTA) chelation as a treatment for acquired hepatocerebral degeneration. Background: Acquired hepatocerebral degeneration is a rare…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.